Itzehoe, Germany

Ralf Schliephacke

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Norderstedt, DE (2003)
  • Itzehoe, DE (2002 - 2017)

Company Filing History:


Years Active: 2002-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ralf Schliephacke: Innovator in Oral Active Ingredient Films

Introduction

Ralf Schliephacke is a notable inventor based in Itzehoe, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral active ingredient films. With a total of 4 patents to his name, Schliephacke's work has the potential to impact the way medications are delivered and consumed.

Latest Patents

One of Schliephacke's latest patents is a method for producing and monitoring oral active ingredient films. This innovative method involves several steps, including metering and mixing a base formulation, coating it onto a substrate to create a strip, and drying the coated strip. Additionally, the process includes printing a colorant solution containing at least one active ingredient onto the upper side of the strip using the flexographic printing method. The final steps involve drying the strip with the printed solution and measuring the transmission of penetrating radiation to ensure quality control.

Another significant patent is for an adhesive tape section designed with a polygon shape or as a circle. This adhesive tape features a central adhesive region and grip tabs around it. When bonded to a substrate, the tape can be released by pulling on the grip tabs, allowing for easy removal without damaging the surface.

Career Highlights

Throughout his career, Ralf Schliephacke has worked with prominent companies such as Tesa AG and Beiersdorf AG. His experience in these organizations has contributed to his expertise in developing innovative solutions in the adhesive and pharmaceutical industries.

Collaborations

Schliephacke has collaborated with notable colleagues, including Uwe Neumann and Hans Hazes. These partnerships have likely fostered a creative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Ralf Schliephacke's contributions to the development of oral active ingredient films and adhesive technologies highlight his innovative spirit and dedication to improving pharmaceutical delivery methods. His patents reflect a commitment to enhancing the efficiency and effectiveness of medication administration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…